Jul. 26 at 8:44 PM
$OTLC Conclusion
Within the scope of this research, a class of cationic quaternary ammonium salt-based drug-eluting microspheres (PMS) were developed by crosslinking PAH with ECH. These microspheres are designed to load the vascular disrupting agent, CA4P, which has the capacity to degrade the established tumor vascular network and suppress the proliferation of neovasculature within the tumor, is not easily resistant. In vitro assessments have substantiated that PMS adhere to the performance standards requisite https://www.sciencedirect.com/science/article/abs/pii/S1742706125005537